Therapeutic Areas: Dermatology | Oncology | Family Medicine

Melanoma Clinical Trials


A listing of Melanoma medical research trials actively recruiting patient volunteers. Click on the closest state and city to find more detailed information on a research study in your area.

Alabama

Birmingham : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Birmingham : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Birmingham : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Mobile : University of South Alabama / Mitchell Cancer Institute SC

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Arizona

Gilbert : Banner MD Anderson Cancer Center

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Goodyear : GSK Investigational Site

A clinical trial to evaluate treatments using Dabrafenib 150 mg twice a day (BID), Rabeprazole 40 mg once daily (OD) and Rifampin 600 mg OD for patients with Cancer

Phoenix : Phoenix Children'S Hospital

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Phoenix : Phoenix Children's Hospital Updated

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Scottsdale : Scottsdale Healthcare

A clinical trial to evaluate treatments using IDC-G305 for patients with Melanoma, Ovarian Cancer, Renal Cell Cancer or Non-small Cell Lung Cancer

Scottsdale : Research Site

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

Scottsdale : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Scottsdale : Mayo Clinic Arizona - Cancer Clinical Research Unit

Patients are needed to participate in a clinical research study evaluating CDX-1127

Scottsdale : Call for Information (Investigational Site 0004)

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Tucson : The University of Arizona Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Tucson : University Arizona Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Tucson : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Tucson : The University of Arizona Cancer Center

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Tucson : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Tucson : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Tucson : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Tucson : Updated

Patients are needed to participate in a clinical research study of Zelboraf (vemurafenib) to evaluate Malignant Melanoma

Arkansas

Fayetteville : Highlands Oncology Group SC

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Fayetteville : Highlands Oncology Group SC

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Fayetteville : Highlands Oncology Group SC

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Hot Springs : Genesis Cancer Center

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Rogers : Updated

Patients are needed to participate in a clinical research study of vemurafenib and rifampin to evaluate Malignant Melanoma, Neoplasms

California

Beverly Hills : Call for Information (Investigational Site 0027)

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Duarte : Teva Investigational Site 10672

A clinical trial to evaluate treatments using CEP-32496 for patients with Solid Tumors, Melanoma or Metastatic Colorectal Cancer

Encinitas : Call for Information (Investigational Site 0030)

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Fresno : Call for Information (Investigational Site 0135)

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

La Jolla : Moores UCSD Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

La Jolla : Moores UCSD Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

La Jolla : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

La Jolla : Moores UCSD Cancer Center

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

La Jolla : Scripps Clinic

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Long Beach : Pacific Shores Medical Group

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Los Angeles : USC Norris Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Los Angeles :

A clinical research study of INCB024360 in combination with ipilimumab and Placebo in combination with ipilimumab for the treatment of Metastatic Melanoma

Los Angeles : Childrens Hospital Of La

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Los Angeles : Jonsson Comprehensive Cancer Center

A clinical research study of sargramostim, sentinel lymph node biopsy, laboratory biomarker analysis and hypertonic saline for the treatment of Stage IB Melanoma, Stage IIA Melanoma, Stage IIB Melanoma or Stage IIC Melanoma

Los Angeles : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Lung Cancer, Non-Small Cell

Los Angeles : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Los Angeles : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Los Angeles : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Los Angeles : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Los Angeles : Updated

A clinical trial to evaluate treatments using DEDN6526A for patients with Malignant Melanoma

Los Angeles : UCLA

A clinical trial to evaluate treatments using PLX3397 and vemurafenib for patients with Melanoma

Los Angeles : GSK Investigational Site

A Phase 1 clinical study for patients with Solid Tumours

Los Angeles :

A Phase 1/Phase 2 clinical study for patients with Advanced Solid Tumors

Los Angeles : Cedars Sinai Medical Center Cedars Sinai 4

A Phase 4 clinical study for patients using Pasireotide

Los Angeles : University of California Los Angeles

Combination of Temozolomide and Sunitinib in Treatment of Patients With Metastatic and Unresectable Malignant Melanoma

Los Angeles : Updated

Patients are needed to participate in a clinical research study evaluating MPDL3280A and Vemurafenib (Zelboraf®) for the treatment of Malignant Melanoma

Los Angeles : Call for Information (Investigational Site 0015)

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Los Angeles : Call for Information (Investigational Site 0010)

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Los Angeles : Updated

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Los Angeles : Updated

Patients are needed to participate in a clinical research study of Zelboraf (vemurafenib) to evaluate Malignant Melanoma

Orange : Children'S Hospital Of Orange County

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Orange : Chao Family Comprehensive Cancer Center

A clinical trial seeking patients for a research study for the treatment of Melanoma or Malignant Melanoma

Orange : Chao Family Comprehensive Cancer Center

Patients are needed to participate in a clinical research study evaluating Pazopanib and Paclitaxel for the treatment of Stage III Melanoma, Stage IV Melanoma or Unresectable Melanoma

Pleasant Hill : Updated

Patients are needed to participate in a clinical research study of vemurafenib and rifampin to evaluate Malignant Melanoma, Neoplasms

Pleasant Hill : Updated

Patients are needed to participate in a clinical research study of vemurafenib and tizanidine to evaluate Malignant Melanoma, Neoplasms

San Francisco : University of San Francisco, California

A clinical research study of Dabrafenib and Gamma Knife Radiosurgery for the treatment of BRAFV600E Melanoma Patients

San Francisco : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

San Francisco : University of California, San Francisco

A clinical trial to evaluate treatments using BKM120 Combined with Vemurafenib (PLX4032) for patients with BRAF Mutant Metastatic Melanoma

San Francisco : GSK Investigational Site

A Phase 1 clinical study for patients with Solid Tumours

San Francisco : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

San Francisco : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

San Francisco : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

San Francisco : Call for Information (Investigational Site 0008)

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

San Francisco : UCSF Helen Diller Comprehensive Cancer Center

Patients are needed to participate in a clinical research study of Plasmid INTERLEUKIN-12 and Intratumoral Electroporation to evaluate Melanoma

San Luis Obispo : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Santa Monica : Sarcoma Oncology Center

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Santa Monica :

A Phase 1/Phase 2 clinical study for patients with Advanced Solid Tumors

Santa Monica :

A Phase 1/Phase 2 clinical study for patients with Unresectable Stage III or IV Melanoma

Santa Monica : John Wayne Cancer Institute

Patients are needed to participate in a clinical research study of Plasmid INTERLEUKIN-12 and Intratumoral Electroporation to evaluate Melanoma

Santa Monica : Updated

Patients are needed to participate in a clinical research study of Zelboraf (vemurafenib) to evaluate Malignant Melanoma

South San Francisco : UCSF Medical Center at Mount Zion

A Phase 1/Phase 2 clinical study for patients with Advanced or Inoperable Malignant Melanoma With BRAF Mutation

Stanford : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Stanford : Stanford Cancer Center - Stanford University

Patients are needed to participate in a clinical research study evaluating CDX-1127

Valencia : Sanguine Biosciences

Patients are needed to participate in a clinical research study for the treatment of All Diagnosed Health Conditions

Vallejo : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Colorado

Aurora : University of Colorado Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Aurora : Children'S Hospital Colorado

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Aurora : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Aurora : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Aurora : University of Colorado Dept of Oncology

Patients are needed to participate in a clinical research study evaluating LEE011 and LGX818 for the treatment of Locally Advanced or Metastatic BRAF Mutant Melanoma

Aurora : Updated

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Aurora : Updated

Patients are needed to participate in a clinical research study of Zelboraf (vemurafenib) to evaluate Malignant Melanoma

Denver : Rocky Mountain Cancer Centers

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Grand Junction : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Connecticut

New Haven : Smilow Cancer Hospital at Yale New Haven

A clinical trial to evaluate treatments using Vemurafenib for patients with Melanoma [C04.557.465.625.650.510]

New Haven : Yale Cancer Center

A Phase 1 clinical study for patients with Malignant Melanoma

New Haven : Yale School of Medicine

Patients are needed to participate in a clinical research study evaluating NY-ESO-1 for the treatment of Melanoma

New Haven : Call for Information (Investigational Site 0028)

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

District of Columbia

Washington : Georgetown Lombardi Comprehsnive Cancer Center

A Phase 2 clinical study for patients with Melanoma

Washington : Washington Cancer Institute at MedStar Washington Hospital Center

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Washington : Georgetown University Medical Center

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Washington : Call for Information (Investigational Site 0003) Updated

Patients are needed to participate in a clinical research study of MK-3475, PegIFN-2b and Ipilimumab to evaluate Renal Cell Carcinoma or Melanoma

Florida

Boynton Beach : University Cancer Institute SC

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Fort Myers : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Fort Myers : Teva Investigational Site 10673

A clinical trial to evaluate treatments using CEP-32496 for patients with Solid Tumors, Melanoma or Metastatic Colorectal Cancer

Fort Myers : Florida Cancer Specialists Dept of Onc

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Fort Myers : Florida Cancer Specialists SC

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Fort Myers : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Fort Myers : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Hollywood : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Jacksonville : Call for Information (Investigational Site 0003)

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Lakeland : Lakeland Regional Cancer Center

Patients are needed to participate in a clinical research study of Plasmid INTERLEUKIN-12 and Intratumoral Electroporation to evaluate Melanoma

Miami :

A clinical research study of INCB024360 in combination with ipilimumab and Placebo in combination with ipilimumab for the treatment of Metastatic Melanoma

Miami :

A Phase 1/Phase 2 clinical study for patients with Advanced Solid Tumors

Miami Beach : Mount Sinai Medical Center Comprehensive Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Miami Beach : MSMC Research Program

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Miami Beach : MSMC Research Program

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Miami Beach : Research Site

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

Miami Beach : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Miami Beach : Mount Sinai Medical Center

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Orlando : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Orlando : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Orlando : MD Anderson Cancer Center Orlando

Patients are needed to participate in a clinical research study evaluating DCVax-Direct

Orlando : MD Anderson Cancer Center Orlando

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Sarasota : Updated

A clinical trial to evaluate treatments using DEDN6526A for patients with Malignant Melanoma

Sarasota : Updated

Patients are needed to participate in a clinical research study evaluating MPDL3280A and Vemurafenib (Zelboraf®) for the treatment of Malignant Melanoma

St. Petersburg : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

St. Petersburg : Updated

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Stuart : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Tallahassee : Dermatology Associates of Tallahassee

A clinical study for patients with Melanoma

Tampa : H. Lee Moffitt Cancer Center and Research Institute

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Tampa :

A clinical research study of INCB024360 in combination with ipilimumab and Placebo in combination with ipilimumab for the treatment of Metastatic Melanoma

Tampa : H. Lee Moffitt Cancer Center & Research Institute

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Tampa : H. Lee Moffitt Cancer Center & Research Institute Moffitt SC

A clinical research study of LGX818 for the treatment of Melanoma and Metastatic Colorectal Cancer

Tampa : H. Lee Moffitt Cancer Center

A clinical trial to evaluate treatments using IDC-G305 for patients with Melanoma, Ovarian Cancer, Renal Cell Cancer or Non-small Cell Lung Cancer

Tampa : H. Lee Moffitt Cancer Center and Research Institute

A clinical trial to evaluate treatments using PV-10 and Surgery for patients with Melanoma

Tampa : H. Lee Moffitt Cancer Center and Research Institute

A Phase 1 clinical study for patients with Melanoma (Skin)

Tampa : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Tampa : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Tampa : H. Lee Moffitt Cancer Center and Research Institute

Patients are needed to participate in a clinical research study evaluating Panobinostat and Ipilimumab for the treatment of Melanoma or Skin Cancer

Tampa : H. Lee Moffitt Cancer Center

Patients are needed to participate in a clinical research study evaluating PX-866 in combination with vemurafenib for the treatment of Advanced BRAF-mutant Cancers

Tampa : H. Lee Moffitt Cancer Center and Research Institute

Patients are needed to participate in a clinical research study for the treatment of Metastatic Melanoma

Tampa : H. Lee Moffitt Cancer Center and Research Institute

Patients are needed to participate in a clinical research study of MAGE-A3 ASCI injections without Poly IC:LC and MAGE-A3 ASCI injections with Poly IC:LC to evaluate Melanoma

Tampa : H. Lee Moffitt Cancer Center & Research Institute

Patients are needed to participate in a clinical research study of Nivolumab and Ipilimumab to evaluate Advanced or Metastatic Melanoma

Tampa : H. Lee Moffitt Cancer Center and Research Institute

Patients are needed to participate in a clinical research study of XL888 and Vemurafenib to evaluate Melanoma

Tampa : Updated

Patients are needed to participate in a clinical research study of Zelboraf (vemurafenib) to evaluate Malignant Melanoma

Tampa : H. Lee Moffitt Cancer Center and Research Institute

Patients are needed to participate in a clinical research study to evaluate Melanoma (Skin)

West Palm Beach : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Georgia

Savannah : Memorial University Medical Center

CTSU/ECOG E1609: A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High Dose Interferon a-2b for Resected High-Risk Melanoma

Athens : University Cancer & Blood Center, LLC

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Atlanta : Emory University Winship Cancer Institute

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Atlanta : Emory University School of Medicine

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Atlanta : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Atlanta : Call for Information (Investigational Site 0026)

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Atlanta : Taofeek Owonikoko, MD, PhD

Patients are needed to participate in a clinical research study of BKM120 and Everolimus to evaluate Solid Tumors

Atlanta : Emory University/Winship Cancer Institute

Patients are needed to participate in a clinical research study of IDO1 inhibitor INCB024360, MELITAC 12.1 peptide vaccine and laboratory biomarker analysis

Atlanta : Updated

Patients are needed to participate in a clinical research study of Zelboraf (vemurafenib) to evaluate Malignant Melanoma

Augusta : Georgia Regents University

Patients are needed to participate in a clinical research study of NLG919 to evaluate Solid Tumors, Breast Cancer, Lung Cancer or Pancreatic Cancer

Tucker : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Illinois

Elgin : Sherman Health

ECOG E1609 Phase III Randomized Study of Adjuvant Ipilimumab Versus High-Dose Recombinant Interferon Alfa-2b in Patients With High-Risk Stage IIIB, IIIC, or IV Melanoma

Chicago :

A clinical research study of INCB024360 in combination with ipilimumab and Placebo in combination with ipilimumab for the treatment of Metastatic Melanoma

Chicago : Robert H. Lurie Comprehensive Cancer Center, Northwestern University

Patients are needed to participate in a clinical research study of ALS-357 to evaluate Melanoma

Maywood : Loyola University Medical Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Maywood : Loyola University Medical Center, Div of Hematology/Oncology

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Maywood : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Niles : Oncology Specialists, S.C

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Park Ridge : Oncology Specialists, SC

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Park Ridge : Luther General Cancer Care Institute

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Park Ridge : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Lung Cancer, Non-Small Cell

Park Ridge : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Park Ridge : Oncology Specialists, SC

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Park Ridge : Oncology Specialists, SC SC - 5

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Park Ridge : Updated

Patients are needed to participate in a clinical research study of Zelboraf (vemurafenib) to evaluate Malignant Melanoma

Peoria : Illinois Cancer Care

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Indiana

Goshen : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Goshen :

A Phase 1/Phase 2 clinical study for patients with Unresectable Stage III or IV Melanoma

Goshen : Indiana University Health Goshen Center for Cancer SC

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Indianapolis : Indiana University Melvin and Bren Simon Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Indianapolis : Indiana University

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Indianapolis : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Indianapolis : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Indianapolis :

A Phase 1/Phase 2 clinical study for patients with Unresectable Stage III or IV Melanoma

Indianapolis : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Indianapolis : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Indianapolis : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Iowa

Iowa City : University of Iowa Hospitals and Clinics

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Iowa City : University of Iowa Hospitals and Clinics

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Iowa City : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Iowa City : University of Iowa Hospitals & Clinics

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Iowa City : University of Iowa Hospitals and Clinics

Patients are needed to participate in a clinical research study evaluating Temozolomide, Decitabine, Panobinostat for the treatment of Metastatic Melanoma

Iowa City : University of Iowa Hospitals & Clinics

Patients are needed to participate in a clinical research study evaluating Vemurafenib, Decitabine for the treatment of Metastatic Melanoma, Melanoma, BRAF-mutated Metastatic Melanoma or V600EBRAF-mutated Metastatic Melanoma

Kansas

Kansas City : University of Kansas Hospital

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Wichita : Cancer Center of Kansas

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Kentucky

Louisville : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Louisville : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Louisville :

A Phase 1/Phase 2 clinical study for patients with Unresectable Stage III or IV Melanoma

Louisville : James Graham Brown Cancer Center

Patients are needed to participate in a clinical research study of A-dmDT390-bisFv(UCHT1) and Ionizing Radiation to evaluate Melanoma

Louisiana

Baton Rouge : The Baton Rouge Clinic, AMC

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Baton Rouge : Hematology/Oncology Clinic

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

New Orleans : Tulane University

Patients are needed to participate in a clinical research study evaluating 4-Demethyl-4-cholestryloxycarbonylpenclomedine for the treatment of Primary Brain Tumors or Secondary Brain Tumors

Maine

Bangor : Eastern Maine Medical Center Research Center SC

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Maryland

Baltimore : The Johns Hopkins University

A clinical study for patients with Melanoma

Baltimore : Weinberg Cancer Institute at Franklin Square Hospital Dept of Oncology

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Baltimore : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Baltimore : Harry and Jeannette Weinberg Cancer Institute at Franklin Square

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Bethesda : Updated

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Lutherville : Johns Hopkins

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Lutherville : Johns Hopkins Medicine

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Lutherville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Rockville : Associates in Oncology/Hematology, P.C. Dept. of Assoc. Onc/Hem

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Massachusetts

Boston : Massachusetts General Hospital

A clinical study for patients with Melanoma

Boston : Beth Israel Deaconess Medical Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Boston : Dana-Farber Cancer Institute

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Boston : Massachusetts General Hospital

A clinical research study of STA-9090 for the treatment of Ocular Melanoma

Boston : Dana-Farber Cancer Institute

A clinical research study of STA-9090 for the treatment of Ocular Melanoma

Boston : Dana Farber Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma or Metastatic Melanoma

Boston : Dana Farber Cancer Institute

A clinical trial to evaluate treatments using AM0010 in Patients With Advanced Solid Tumors

Boston : Dana Farber Cancer Institute

A clinical trial to evaluate treatments using MGA271 for patients

Boston : Massachusetts General Hospital Cancer Center

A clinical trial to evaluate treatments using MGA271 for patients

Boston : Dana Farber Cancer Institute DFCI - Brookline

A Phase 1 clinical study for patients with Uveal Melanoma

Boston : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Boston : Massachusetts General Hospital SC -6

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Boston : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Boston : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Boston : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Boston : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Boston : Updated

Patients are needed to participate in a clinical research study evaluating MPDL3280A and Vemurafenib (Zelboraf®) for the treatment of Malignant Melanoma

Boston : Updated

Patients are needed to participate in a clinical research study evaluating MPDL3280A and Vemurafenib (Zelboraf®) for the treatment of Malignant Melanoma

Boston : Massachusetts Eye & Ear Infirmary

Patients are needed to participate in a clinical research study evaluating ranibizumab for the treatment of Choroidal Melanoma

Boston : Dana-Farber Cancer Institute

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Boston : Beth Israel Deaconess Medical Center (BIDMC)

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Boston : Call for Information (Investigational Site 0011)

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Boston : Massachusetts General Hospital Cancer Center

Patients are needed to participate in a clinical research study of MGA271 to evaluate Melanoma

Boston : Dana Farber Cancer Institute

Patients are needed to participate in a clinical research study of Nivolumab and Ipilimumab to evaluate Advanced or Metastatic Melanoma

Boston : Dana-Farber Cancer Institute

Patients are needed to participate in a clinical research study of Nivolumab and Ipilimumab to evaluate Advanced or Metastatic Melanoma

Boston : Updated

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Rockland : Please Contact U.S. Medical Information Located in

A clinical trial seeking patients for a research study for the treatment of Melanoma

Rockland : Please contact the US Medical Information in

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Michigan

Ann Arbor : University of Michigan Health System

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Ann Arbor : University of Michigan, Comprehensive Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Ann Arbor : University of Michigan Int. Medicine Oncology

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Ann Arbor : University of Michigan Comprehensive Cancer Center SC-2

A Phase 4 clinical study for patients using Pasireotide

Ann Arbor : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Detroit : Barbara Ann Karmanos Cancer Institute

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Detroit : Karmanos Cancer Institute

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Detroit : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Detroit : Karmanos Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Detroit : Teva Investigational Site 10670

A clinical trial to evaluate treatments using CEP-32496 for patients with Solid Tumors, Melanoma or Metastatic Colorectal Cancer

Detroit : Updated

A clinical trial to evaluate treatments using DEDN6526A for patients with Malignant Melanoma

Detroit : Karmanos Cancer Institute

A clinical trial to evaluate treatments using IDC-G305 for patients with Melanoma, Ovarian Cancer, Renal Cell Cancer or Non-small Cell Lung Cancer

Detroit : Wayne State University/Karmanos Cancer Institute Wayne St

A Phase 1 clinical study for patients using LGK974

Detroit : Wayne State University/Karmanos Cancer Institute SC - 1

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Detroit : Wayne State University/Karmanos Cancer Institute Dept of Oncology

Patients are needed to participate in a clinical research study evaluating LEE011 and LGX818 for the treatment of Locally Advanced or Metastatic BRAF Mutant Melanoma

Detroit : Wayne State University/Karmanos Cancer Institute Dept of Oncology

Patients are needed to participate in a clinical research study of LEE011 and MEK162 to evaluate Locally Advanced or Metastatic NRAS Mutant Melanoma

Detroit : Updated

Patients are needed to participate in a clinical research study of vemurafenib and tizanidine to evaluate Malignant Melanoma, Neoplasms

St. Louis : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Minnesota

Minneapolis : University of Minnesota Masonic Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Minneapolis : University of Minnesota Masonic Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Rochester : Mayo Clinic

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Rochester : Mayo Clinic

Patients are needed to participate in a clinical research study evaluating CDX-1127

Rochester : Call for Information (Investigational Site 0002)

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Mississippi

Hattiesburg : Forest General Hospital

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Missouri

Kansas City : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Kansas City : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Manchester : Mercy Medical Research Institute SC-1

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

St. Louis : Saint Louis University Cancer Cener

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

St. Louis : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Lung Cancer, Non-Small Cell

St. Louis : Teva Investigational Site 10671

A clinical trial to evaluate treatments using CEP-32496 for patients with Solid Tumors, Melanoma or Metastatic Colorectal Cancer

St. Louis : GSK Investigational Site

A Phase 1 clinical study for patients with Solid Tumours

St. Louis :

A Phase 1/Phase 2 clinical study for patients with Unresectable Stage III or IV Melanoma

St. Louis : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

St. Louis : Saint Louis University Hospital

Patients are needed to participate in a clinical research study evaluating Fosaprepitant for the treatment of Chemotherapy-induced Nausea and Vomiting

St. Louis : Washington University in St. Louis

Patients are needed to participate in a clinical research study evaluating NY-ESO-1 for the treatment of Melanoma

St. Louis : Updated

Patients are needed to participate in a clinical research study of Zelboraf (vemurafenib) to evaluate Malignant Melanoma

Nebraska

Lincoln : Southeast Nebraska Hematology & Oncology Consultants

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Omaha : Midwest Cancer Center - Legacy

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Omaha : Nebraska Cancer Specialists, Midwest Cancer Center - Legacy

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Omaha : Nebraska Methodist Hospital Estabrook Cancer Center

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Nevada

Las Vegas : Comprehensive Cancer Centers of Nevada CCC of Nevada- Southwest (2)

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Las Vegas : Comprehensive Cancer Centers of Nevada CCC of Nevada (1)

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Las Vegas : Comprehensive Cancer Centers of Nevada

Patients are needed to participate in a clinical research study of Blood Draw to evaluate Melanoma

Las Vegas : Comprehensive Cancer Centers of Nevada

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

New Hampshire

Lebanon : Dartmouth Hitchcock Medical Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Lebanon : Dartmouth-Hitchcock Medical Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Lebanon : Dartmouth Hitchcock Medical Center

Patients are needed to participate in a clinical research study of IDO1 inhibitor INCB024360, MELITAC 12.1 peptide vaccine and laboratory biomarker analysis

New Jersey

Basking Ridge : Memorial Sloan-Kettering Cancer Center at Basking Ridge

A clinical research study of LGX818 for the treatment of Melanoma

Camden : Cooper Cancer Center SC

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Hackensack : Hackensack University Medical Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Hackensack : John Theurer Cancer Center at Hackensack University Medical Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Morristown :

A Phase 1/Phase 2 clinical study for patients with Unresectable Stage III or IV Melanoma

Morristown : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Morristown : Updated

Patients are needed to participate in a clinical research study of Zelboraf (vemurafenib) to evaluate Malignant Melanoma

New Brunswick : Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School

Effects of Monoclonal Antibody GC1008 in Blood Samples From Patients With Unresectable Locally Advanced or Metastatic Kidney Cancer or Malignant Melanoma Treated on Clinical Trial NCI-06-C-0200

Randolph : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Verona : The Dermatology Group, P.C.

A clinical study for patients with Melanoma

New York

Bronx : Montefiore Medical Center

A clinical trial seeking patients for a research study for the treatment of Refractory Head and Neck Cancer, Squamous Cell Carcinoma, Skin, Carcinoma of the Breast or Malignant Melanoma

Buffalo : Roswell Park Cancer Institute Updated

Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed By Surgery

Commack : Memorial Sloan-Kettering Cancer Center at Commack

A clinical research study of LGX818 for the treatment of Melanoma

New York : Columbia University/Herbert Irving Comprehensive Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

New York : Saint Luke's-Roosevelt Hospital Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

New York : Memorial Sloan Kettering Cancer Center

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

New York : Memorial Sloan-Kettering Cancer Center

A clinical research study of LGX818 for the treatment of Melanoma

New York : Melanoma and Sarcoma Service / Memorial Sloan Kettering Cancer Center

A clinical research study of TRX518 for the treatment of Unresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor Malignancies

New York : Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

New York : Memorial Sloan Kettering Cancer Ctr

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma or Metastatic Melanoma

New York : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

New York : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

New York : New York University Langone Clinical Cancer Center

A clinical trial seeking patients for a research study for the treatment of Melanoma

New York : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

New York : Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

New York : Memorial Sloan Kettering Cancer Center

A clinical trial to evaluate treatments using AM0010 in Patients With Advanced Solid Tumors

New York : Memorial Sloan Kettering Cancer Center

A clinical trial to evaluate treatments using Dabrafenib for patients with Melanoma

New York : GSK Investigational Site

A Phase 1 clinical study for patients with Solid Tumours

New York : Memorial Sloan Kettering Cancer Center MSKCC 4

A Phase 1 clinical study for patients with Uveal Melanoma

New York : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

New York : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

New York : Memorial Sloan Kettering Cancer Center

Patients are needed to participate in a clinical research study evaluating Ipilimumab, Melphalan and Dactinomycin for the treatment of Melanoma

New York : Memorial Sloan Kettering Cancer Center Dept Oncology

Patients are needed to participate in a clinical research study evaluating LEE011 and LGX818 for the treatment of Locally Advanced or Metastatic BRAF Mutant Melanoma

New York : New York University

Patients are needed to participate in a clinical research study evaluating PX-866 in combination with vemurafenib for the treatment of Advanced BRAF-mutant Cancers

New York : NYU Clinical Cancer Center

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

New York : NYU Langone Medical Center

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

New York : Call for Information (Investigational Site 0019)

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

New York : Memorial Sloan Kettering Cancer Center Dept Oncology

Patients are needed to participate in a clinical research study of LEE011 and MEK162 to evaluate Locally Advanced or Metastatic NRAS Mutant Melanoma

New York : Mount Sinai School of Medicine

Patients are needed to participate in a clinical research study of Poly-ICLC

New York : Memorial Sloan-Kettering Cancer Center

Patients are needed to participate in a clinical research study of RAD001 (Everolimus) and Pasireotide (SOM230) LAR to evaluate Uveal Melanoma

New York : Updated

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

New York : Icahn School of Medicine at Mount Sinai

Patients are needed to participate in a clinical research study of Vemurafenib to evaluate Melanoma

New York : Updated

Patients are needed to participate in a clinical research study of Zelboraf (vemurafenib) to evaluate Malignant Melanoma

Rockville Centre : Memorial Sloan-Kettering Cancer Center at Mercy Medical Center

A clinical research study of LGX818 for the treatment of Melanoma

Sleepy Hollow : Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center

A clinical research study of LGX818 for the treatment of Melanoma

North Carolina

Chapel Hill : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Chapel Hill : Lineberger Comprehensive Cancer Center, University of North Carolina

A Phase 2 clinical study for patients with Stage III Melanoma, Stage IV Melanoma, Unresectable Melanoma or BRAF Mutant Melanoma

Chapel Hill : UNC Lineberger Comprehensive Cancer Center

Patients are needed to participate in a clinical research study evaluating 2B3-101, Trastuzumab, 2B3-101 60 mg/m2 every 4 weeks and 2B3-101 50 mg/m2 every 3 weeks

Charlotte : Blumenthal Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Durham : Duke University Medical Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Durham :

A clinical research study of INCB024360 in combination with ipilimumab and Placebo in combination with ipilimumab for the treatment of Metastatic Melanoma

Durham : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Durham : Duke University Health System

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Durham : Duke University Medical Center

Patients are needed to participate in a clinical research study of IDO1 inhibitor INCB024360, MELITAC 12.1 peptide vaccine and laboratory biomarker analysis

Durham : Updated

Patients are needed to participate in a clinical research study of vemurafenib and tizanidine to evaluate Malignant Melanoma, Neoplasms

Winston-Salem : Wake Forest University Baptist Medical Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Ohio

Canton : Gabrail Cancer Center Research

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Cincinnati : The Christ Hospital Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Cincinnati : The Christ Hospital Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Cincinnati : The Christ Hospital

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Cincinnati : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Cleveland : University Hospitals Siedman Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Cleveland : Taussig Cancer Institute / Cleveland Clinic Foundation

A clinical research study of TRX518 for the treatment of Unresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor Malignancies

Cleveland : Siedman Cancer Center / University Hospitals of Cleveland

A clinical research study of TRX518 for the treatment of Unresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor Malignancies

Cleveland : Case Comprehensive Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Columbus : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Columbus : The Ohio State University Comprehensive Cancer Center

Patients are needed to participate in a clinical research study evaluating CDX-1127

Columbus : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Columbus : Ohio State University

Patients are needed to participate in a clinical research study evaluating Ipilimumab, Whole-Brain Radiation Therapy (WBRT) and Stereotactic Radiosurgery (SRS) for the treatment of Recurrent Melanoma, Stage IV Melanoma or Tumors Metastatic to Brain

Columbus : Updated

Patients are needed to participate in a clinical research study of Zelboraf (vemurafenib) to evaluate Malignant Melanoma

Middletown : Updated

Patients are needed to participate in a clinical research study of vemurafenib and rifampin to evaluate Malignant Melanoma, Neoplasms

Oregon

Portland : Providence Portland Medical Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Portland : Providence Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Portland : Providence Portland Medical Center

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma or Metastatic Melanoma

Portland : Providence Cancer Center

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Portland : Oregon Health and Science University

A clinical trial seeking patients for a research study for the treatment of Refractory Head and Neck Cancer, Squamous Cell Carcinoma, Skin, Carcinoma of the Breast or Malignant Melanoma

Portland : Northwest Cancer Specialists Compass Oncology - SC

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Portland : Oregon Health & Science University SC-7

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Portland : Kaiser Permanente Northwest Dept of Kaiser Northwest (3)

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Portland : Oregon Health and Science University

Patients are needed to participate in a clinical research study evaluating CDX-1127

Portland : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Portland : Oregon Health & Science University Dept. of OHSU (3)

Patients are needed to participate in a clinical research study evaluating LEE011 and LGX818 for the treatment of Locally Advanced or Metastatic BRAF Mutant Melanoma

Portland : Providence Portland Medical Center

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Pennsylvania

Bethlehem : Saint Luke's Hospital and Health Network

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Bethlehem : St Luke's University Hospital and Health Network

A clinical trial seeking patients for a research study for the treatment of Melanoma

Bethlehem : St. Luke's Cancer Center

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Easton : St. Luke's Hospital, Anderson Campus

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Hershey : Penn State University / Milton S. Hershey Medical Center SC-2

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Philadelphia :

A clinical research study of INCB024360 in combination with ipilimumab and Placebo in combination with ipilimumab for the treatment of Metastatic Melanoma

Philadelphia : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Philadelphia : Teva Investigational Site 10669

A clinical trial to evaluate treatments using CEP-32496 for patients with Solid Tumors, Melanoma or Metastatic Colorectal Cancer

Philadelphia : Hospital of the University of Pennsylvania/Abramson Cancer Center

A clinical trial to evaluate treatments using MGA271 for patients

Philadelphia : Fox Chase Cancer Center

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Philadelphia : University of Pennsylvania Medical Center SC - 2

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Philadelphia : Thomas Jerfferson University Hospital SC

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Philadelphia : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Philadelphia : Thomas Jefferson University

Patients are needed to participate in a clinical research study evaluating Ipilimumab, Whole-Brain Radiation Therapy (WBRT) and Stereotactic Radiosurgery (SRS) for the treatment of Recurrent Melanoma, Stage IV Melanoma or Tumors Metastatic to Brain

Philadelphia : University of Pennsylvania

Patients are needed to participate in a clinical research study evaluating PX-866 in combination with vemurafenib for the treatment of Advanced BRAF-mutant Cancers

Philadelphia : Call for Information (Investigational Site 0029)

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Philadelphia : Call for Information (Investigational Site 0016)

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Pittsburgh : Hillman Cancer Research Pavilion, Div. of Medical Oncology

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Pittsburgh : Hillman Cancer Center

A clinical research study of Biospecimen banking for the treatment of Melanoma

Pittsburgh : UPMC Cancer Centers

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Pittsburgh : UPMC Hillman Cancer Center

A clinical trial seeking patients for a research study for the treatment of Melanoma

Pittsburgh : University of Pittsburgh

A clinical trial seeking patients for a research study for the treatment of Refractory Head and Neck Cancer, Squamous Cell Carcinoma, Skin, Carcinoma of the Breast or Malignant Melanoma

Pittsburgh : University of Pittsburgh Medical Center SC-4

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Pittsburgh : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Pittsburgh : University of Pittsburgh Cancer Institute

Patients are needed to participate in a clinical research study evaluating PX-866 in combination with vemurafenib for the treatment of Advanced BRAF-mutant Cancers

Pittsburgh : Call for Information (Investigational Site 0013)

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Pittsburgh : Updated

Patients are needed to participate in a clinical research study of Zelboraf (vemurafenib) to evaluate Malignant Melanoma

Pittsburgh : MD Anderson Cancer Center Orlando

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

South Carolina

Charleston : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Tennessee

Knoxville : University of Tennessee Medical Center

A clinical trial seeking patients for a research study for the treatment of Stage IV Melanoma or Metastatic Melanoma

Memphis : St. Jude Children'S Research Hospital

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Memphis : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Memphis : The West Clinic

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Memphis : Updated

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Nashville : Vanderbilt-Ingram Cancer Ctr

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma or Metastatic Melanoma

Nashville : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Nashville : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Nashville : Sarah Cannon Research Institute Onc Dept

A clinical trial seeking patients for a research study for the treatment of Melanoma

Nashville : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Nashville : Sarah Cannon Research Institute Tennessee Oncology

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Nashville : Sarah Cannon Research Institute

A clinical trial to evaluate treatments using AM0010 in Patients With Advanced Solid Tumors

Nashville : Updated

A clinical trial to evaluate treatments using DEDN6526A for patients with Malignant Melanoma

Nashville : Sarah Cannon Research Institute

A clinical trial to evaluate treatments using MGA271 for patients

Nashville : Vanderbilt University

A clinical trial to evaluate treatments using PLX3397 and vemurafenib for patients with Melanoma

Nashville : Sarah Cannon Research Institute

A Phase 1 clinical study for patients with Malignant Melanoma

Nashville : GSK Investigational Site

A Phase 1 clinical study for patients with Solid Tumours

Nashville :

A Phase 1/Phase 2 clinical study for patients with Advanced Solid Tumors

Nashville : Sarah Cannon Research Institute SC - 2

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Nashville : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Nashville : Sarah Cannon Research Institute

Patients are needed to participate in a clinical research study evaluating CDX-1127

Nashville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Nashville : Vanderbilt University Medical Center SC - Dept of Oncology .

Patients are needed to participate in a clinical research study evaluating LEE011 and LGX818 for the treatment of Locally Advanced or Metastatic BRAF Mutant Melanoma

Nashville : Vanderbilt-Ingram Cancer Center

Patients are needed to participate in a clinical research study evaluating PX-866 in combination with vemurafenib for the treatment of Advanced BRAF-mutant Cancers

Nashville : Call for Information (Investigational Site 0134)

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Nashville : Vanderbilt University Medical Center SC - Dept of Oncology .

Patients are needed to participate in a clinical research study of LEE011 and MEK162 to evaluate Locally Advanced or Metastatic NRAS Mutant Melanoma

Nashville : Updated

Patients are needed to participate in a clinical research study of Zelboraf (vemurafenib) to evaluate Malignant Melanoma

Texas

Dallas : Research Across America

Do You Have Melanoma?

Dallas : Mary Crowley Cancer Research Center

A clinical trial seeking patients for a research study for the treatment of Refractory Head and Neck Cancer, Squamous Cell Carcinoma, Skin, Carcinoma of the Breast or Malignant Melanoma

Dallas : Mary Crowley Cancer Research Centers

A clinical trial to evaluate treatments using pbi-shRNA STMN1 LP for patients with Advanced Cancer, Metastatic Cancer or Solid Tumors

Dallas :

A Phase 1/Phase 2 clinical study for patients with Unresectable Stage III or IV Melanoma

Dallas : Mary Crowley Medical Center

A Phase 2 clinical study for patients with Melanoma

Dallas : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Dallas : Baylor Health Care System/Sammons Cancer Center Oncology

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Dallas : Mary Crowley Cancer Research Centers - Medical City

Patients are needed to participate in a clinical research study evaluating CDX-1127

Dallas : Updated

Patients are needed to participate in a clinical research study of vemurafenib and rifampin to evaluate Malignant Melanoma, Neoplasms

Dallas : Updated

Patients are needed to participate in a clinical research study of Zelboraf (vemurafenib) to evaluate Malignant Melanoma

Houston : MD Anderson Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Houston : The University of Texas MD Anderson Cancer Center

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Houston : UT MD Anderson Cancer Center

A clinical research study of LOC-paclitaxel for the treatment of Melanoma

Houston : The University Of Texas Md Anderson Cancer Center

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma or Metastatic Melanoma

Houston : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Houston : The University of Texas MD Anderson Cancer Center

A clinical trial seeking patients for a research study for the treatment of Melanoma

Houston : MD Anderson Cancer Center

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Houston : Oncology Consultants Oncology Group

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Houston : MD Anderson Cancer Center/University of Texas MD Anderson Cancer Center (3)

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Houston : UT MD Anderson Cancer Center Updated

A clinical trial to evaluate treatments using HDIL-2 and recMAGE-A3 + AS15 for patients with Melanoma

Houston : University of Texas MD Anderson Cancer Center

A clinical trial to evaluate treatments using investigational drug INGN 241 for patients with Malignant Melanoma or Neoplasm Metastasis

Houston : University of Texas/MD Anderson Cancer Center MD Anderson 2

A Phase 1 clinical study for patients using LGK974

Houston : MD Anderson Cancer Center

A Phase 1 clinical study for patients with Metastatic Melanoma or Other Advanced Solid Tumors

Houston : GSK Investigational Site

A Phase 1 clinical study for patients with Solid Tumours

Houston : The University of Texas, MD Anderson Cancer Center

A Phase 1/Phase 2 clinical study for patients with Advanced or Inoperable Malignant Melanoma With BRAF Mutation

Houston : University of Texas MD Anderson Cancer Center

A Phase 2 clinical study for patients with Melanoma

Houston : UT MD Anderson Cancer Center

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Houston : MD Anderson Cancer Center

Patients are needed to participate in a clinical research study evaluating DCVax-Direct

Houston : Updated

Patients are needed to participate in a clinical research study evaluating MPDL3280A and Vemurafenib (Zelboraf®) for the treatment of Malignant Melanoma

Houston : Call for Information (Investigational Site 0012)

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Houston : UT MD Andreson Cancer Center Updated

Patients are needed to participate in a clinical research study of GSK2118436 and GSK1120212 to evaluate Melanoma

Houston : UT MD Anderson Cancer Center

Patients are needed to participate in a clinical research study of Ipilimumab to evaluate Melanoma

Houston : University of Texas/MD Anderson Cancer Center Dept of Onc.

Patients are needed to participate in a clinical research study of LEE011 and MEK162 to evaluate Locally Advanced or Metastatic NRAS Mutant Melanoma

Houston : Updated

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Houston : The University of Texas MD Anderson Cancer Center Updated

Patients are needed to participate in a clinical research study to evaluate Melanoma

San Antonio : South Texas Accelerated Research Therapeutics

A clinical trial to evaluate treatments using AM0010 in Patients With Advanced Solid Tumors

San Antonio : The START Center

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

San Antonio :

A Phase 1/Phase 2 clinical study for patients with Advanced Solid Tumors

San Antonio : Call for Information (Investigational Site 0001)

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Tyler : Tyler Cancer Center

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Utah

Salt Lake City : Huntsman Cancer Institute

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Salt Lake City : Primary Children's Medical Center

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Salt Lake City : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Salt Lake City : Huntsman Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Refractory Head and Neck Cancer, Squamous Cell Carcinoma, Skin, Carcinoma of the Breast or Malignant Melanoma

Salt Lake City : Huntsman Cancer Institute

A Phase 2 clinical study for patients with Melanoma

Vermont

Burlington :

A Phase 1/Phase 2 clinical study for patients with Unresectable Stage III or IV Melanoma

Virginia

Charlottesville : University of Virginia

A clinical trial seeking patients for a research study for the treatment of Melanoma

Charlottesville : University of Virginia

A Phase 1 clinical study for patients with Melanoma

Charlottesville : University of Virginia Health System

Patients are needed to participate in a clinical research study evaluating CDX-1127

Charlottesville : University of Virginia

Patients are needed to participate in a clinical research study of IDO1 inhibitor INCB024360, MELITAC 12.1 peptide vaccine and laboratory biomarker analysis

Washington

Seattle : Swedish Cancer Institute Swedish Cancer Institute (SC)

A Phase 4 clinical study for patients using Pasireotide

Seattle : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Seattle : University of Washington Medical Center

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Seattle : Seattle Cancer Care Alliance

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Seattle : Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Patients are needed to participate in a clinical research study of Plasmid INTERLEUKIN-12 and Intratumoral Electroporation to evaluate Melanoma

Tacoma : Northwest Medical Specialties Hematology/Oncology

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Yakima : Yakima Valley Memorial Hospital North Star Lodge

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

West Virginia

Morgantown : West Virginia University - Clinical Trials Research Unit

ECOG 1609 - A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon α-2b for Resected High-Risk Melanoma

Morgantown : West Virginia University - Clinical Trials Research Unit

GO27826 - A Phase III, Randomized, Double-Blind, Placebo Controlled Study of Vemurafenib RO5185426) Adjuvant Therapy in Patients with Surgically Resected, Cutaneous BRAF-Mutant Melanoma at High Risk for Recurrence

Morgantown : West Virginia University - Clinical Trials Research Unit

N0879: A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, with or without Everolimus for Therapy of Metastatic Malignant Melanoma

Morgantown : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Wisconsin

Franklin : Wheaton Franciscan Cancer Care

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Madison : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Argentina

Buenos Aires : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Buenos Aires : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Buenos Aires : Instituto Médico Alexander Fleming

A clinical trial to evaluate treatments using CSF470 vaccine, BCG, Molgramostim and interferon alpha 2b for patients with Cutaneous Melanoma

Caba : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Caba : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Capital Federal : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Ciudad Autonoma Buenos Aires : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Ciudad Autónoma de Buenos Aires : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Cordoba : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Derqui-Pilar : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Pergamino : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Rio Negro : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Rosario : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Rosario : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Rosario- Santa Fe : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Santa Fe : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Santa Fe : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Viedma : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Australia

Adelaide : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Adelaide : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Adelaide : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Adelaide, SA : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Albury/Wodonga : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Auchenflower : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Box Hill : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Box Hill : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Box Hill : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Cairns : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Camperdown : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Camperdown : Updated

A clinical trial to evaluate treatments using DEDN6526A for patients with Malignant Melanoma

East Melbourne : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

East Melbourne : Updated

A clinical trial to evaluate treatments using DEDN6526A for patients with Malignant Melanoma

Frankston : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Gateshead : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Gateshead : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Greenslopes : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Greenslopes : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Heidelberg : Austin Health, LICR Melbourne Austin Branch

A clinical research study of Bacillus Calmette-Guérin (BCG) vaccine and Ipilimumab for the treatment of Metastatic Melanoma

Heidelberg : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Heidelberg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Herston : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Herston : Updated

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Launceston : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Malvern : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Melbourne : Novartis Investigative Site

A clinical research study of LGX818 for the treatment of Melanoma and Metastatic Colorectal Cancer

Melbourne : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Melbourne : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Nedlands : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Nedlands : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

North Ryde : Merck Sharp & Dohme

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

North Sydney : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

North Sydney : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of NY-ESO-1-positive, Unresectable and Progressive Metastatic Cutaneous Melanoma

North Sydney : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

North Sydney : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

North Sydney : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

North Sydney : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Perth : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Prahran : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Townsville : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Tweed Heads : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Waratah : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Wendouree : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Westmead : Local Institution

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Westmead : Novartis Investigative Site

A clinical research study of LGX818 for the treatment of Melanoma and Metastatic Colorectal Cancer

Westmead : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Westmead : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Westmead : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LEE011 and MEK162 to evaluate Locally Advanced or Metastatic NRAS Mutant Melanoma

Westmead : Updated

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Wodonga : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Wollongong : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Woodville : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Woodville South : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Woolloongabba : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of NY-ESO-1-positive, Unresectable and Progressive Metastatic Cutaneous Melanoma

Woolloongabba : Research site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Woolloongabba : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Woolloongabba : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Woolloongabba : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Austria

Feldkirch : Updated

A clinical research study for the treatment of Malignant Melanoma

Graz : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Graz : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Innsbruck : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Innsbruck : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Linz : Updated

A clinical research study for the treatment of Malignant Melanoma

Linz : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Linz : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Linz : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Salzburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Salzburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Salzburg : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Vienna : Medizinische Universität Wien, Abteilung für Dermatologie

Patients are needed to participate in a clinical research study evaluating RBL001/RBL002 for the treatment of Melanoma

Vienna : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Wels : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Wien : Updated

A clinical research study for the treatment of Malignant Melanoma

Wien : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Wien : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Wien : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Wien : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Belgium

Antwerp : Universitair Ziekenhuis Antwerpen

Patients are needed to participate in a clinical research study evaluating 2B3-101, Trastuzumab, 2B3-101 60 mg/m2 every 4 weeks and 2B3-101 50 mg/m2 every 3 weeks

Antwerpen : Updated

A clinical research study for the treatment of Malignant Melanoma

Antwerpen : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Brugge : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Brussel : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Brussels : Cliniques universitaires Saint-Luc, Centre du Cancer

A Phase 1/Phase 2 clinical study for patients with Melanoma

Brussels : Jules Bordet Institute

Patients are needed to participate in a clinical research study evaluating 2B3-101, Trastuzumab, 2B3-101 60 mg/m2 every 4 weeks and 2B3-101 50 mg/m2 every 3 weeks

Brussels : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Bruxelles : Updated

A clinical research study for the treatment of Malignant Melanoma

Bruxelles : Updated

A clinical research study for the treatment of Malignant Melanoma

Bruxelles : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Bruxelles : Jules Bordet Institute

A clinical trial to evaluate treatments using LTX-315 for patients with Transdermally Accessible Tumours

Bruxelles : Cliniques Universitaires St-Luc, Service d'oncologie médicale

A clinical trial to evaluate treatments using LTX-315 for patients with Transdermally Accessible Tumours

Bruxelles : Updated

A clinical trial to evaluate treatments using vemurafenib and phenprocoumon for patients with Malignant Melanoma, Neoplasms

Bruxelles : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Bruxelles : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Edegem : Updated

A clinical research study for the treatment of Malignant Melanoma

Edegem : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Edegem : Updated

A clinical trial to evaluate treatments using vemurafenib and phenprocoumon for patients with Malignant Melanoma, Neoplasms

Edegem : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Edegem : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Gent : Local Institution

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Gent : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Gent : Updated

A clinical trial to evaluate treatments using vemurafenib and phenprocoumon for patients with Malignant Melanoma, Neoplasms

Hasselt : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Kortrijk : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Leuven : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Leuven : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Leuven : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Liege : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Liege : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Liège : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Wilrijk : Updated

A clinical trial to evaluate treatments using vemurafenib and phenprocoumon for patients with Malignant Melanoma, Neoplasms

Wilrijk : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Wilrijk : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Brazil

Belo Horizonte : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Ijui : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Passo Fundo : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Porto Alegre : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Porto Alegre : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Sao Paulo : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Canada

Edmonton : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Edmonton : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Edmonton : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Edmonton : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Edmonton : Cross Cancer Institute

Patients are needed to participate in a clinical research study of TH-302 to evaluate Metastatic Melanoma

Greenfield Park : Updated

Patients are needed to participate in a clinical research study of vemurafenib and tizanidine to evaluate Malignant Melanoma, Neoplasms

Halifax : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Hamilton : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Hamilton : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Hamilton : Juravinski Cancer Centre

Patients are needed to participate in a clinical research study of TH-302 to evaluate Metastatic Melanoma

Kirkland : Merck Canada

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

London : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

London : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

London : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

London : London Health Sciences Centre

Patients are needed to participate in a clinical research study of TH-302 to evaluate Metastatic Melanoma

Moncton : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Montreal : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Montreal : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Montreal : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Montreal : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Montreal : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Montreal : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Montreal : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Montréall : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Oshawa : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Ottawa : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Ottawa : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Quebec : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Québec : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Saint John : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Sainte-Foy : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Ste-Foy : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Toronto : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Toronto : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Toronto : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Toronto : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Toronto : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Toronto : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Toronto : Princess Margaret Hospital

Patients are needed to participate in a clinical research study of TH-302 to evaluate Metastatic Melanoma

Vancouver : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Windsor : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Winnipeg : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

China

Beijing : Beijing Shijitan Hospital,CMU

A clinical research study of Recombinant hGM-CSF Herpes Simplex Virus Injection for the treatment of Melanoma, Liver Cancer, Pancreatic Cancer or Lung Cancer

Guangzhou : Updated

A Phase 1 clinical study for patients with Malignant Melanoma

Shanghai : Fudan University Shanghai Cancer Center

A clinical research study of Recombinant hGM-CSF Herpes Simplex Virus Injection for the treatment of Melanoma, Liver Cancer, Pancreatic Cancer or Lung Cancer

Croatia

Pula : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Varazdin : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Varazdin : Updated

Patients are needed to participate in a clinical research study of vemurafenib and rifampin to evaluate Malignant Melanoma, Neoplasms

Zagreb : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Zagreb : Updated

Patients are needed to participate in a clinical research study of vemurafenib and rifampin to evaluate Malignant Melanoma, Neoplasms

Czech Republic

Brno : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Brno : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Brno : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Hradec Kralove : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Hradec Kralove : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Olomouc : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Olomouc : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Ostrava : Updated

A clinical research study for the treatment of Malignant Melanoma

Ostrava - Poruba : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Prague : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Praha : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Praha : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Praha 10 : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Praha 10 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Praha 2 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Zlin : Updated

A clinical research study for the treatment of Malignant Melanoma

Zlin : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Denmark

Århus C : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Herlev : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Odense : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Egypt

Alexandria : Updated

Patients are needed to participate in a clinical research study of vemurafenib and rifampin to evaluate Malignant Melanoma, Neoplasms

Cairo : Updated

Patients are needed to participate in a clinical research study of vemurafenib and rifampin to evaluate Malignant Melanoma, Neoplasms

Dakahlia : Updated

Patients are needed to participate in a clinical research study of vemurafenib and rifampin to evaluate Malignant Melanoma, Neoplasms

Tanta : Updated

Patients are needed to participate in a clinical research study of vemurafenib and rifampin to evaluate Malignant Melanoma, Neoplasms

Estonia

Tallinn : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Tallinn : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Tartu : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

France

Angers : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Avignon Cedex 2 : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Bayonne : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Besancon : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Besançon : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Besançon Cedex : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Bordeaux : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Bordeaux : Hôpital Saint-André

A clinical trial to evaluate treatments using DT01 for patients with Local Metastatic Melanoma

Bordeaux : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Bordeaux : CHU Hôpital Saint André

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Bordeaux : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Bordeaux : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Bordeaux : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Boulogne Billancourt : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Boulogne Billancourt : AP-HP Hôpital Ambroise Paré

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Boulogne sur Mer : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Boulogne-Billancourt : Hôpital Ambroise Paré

A clinical trial to evaluate treatments using DT01 for patients with Local Metastatic Melanoma

Boulogne-Billancourt : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Boulogne-Billancourt : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Brest : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Brest : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Brest cedex : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Brest Cedex : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Bron Cedex : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Caen : CHRU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Dijon : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Lung Cancer, Non-Small Cell

Dijon : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Dijon : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Grenoble : CHU Michallon

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Grenoble : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Le Kremlin Bicetre : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Le Mans : CH

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Le Mans Cedex 09 : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Lille : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Lung Cancer, Non-Small Cell

Lille : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Lille : Centre Oscar Lambret

A clinical trial to evaluate treatments using DT01 for patients with Local Metastatic Melanoma

Lille : CHRU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Lille : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Lille : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Lille Cedex : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Limoges : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Lyon : Local Institution

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Lyon : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Lyon : Institute for Pediatric Hemato-Oncology, Leon Berard Cancer Center Updated

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Lyon Cedex 08 : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Lyon sud : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Marseille : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Marseille : Hôpital de la Timone

A clinical trial to evaluate treatments using DT01 for patients with Local Metastatic Melanoma

Marseille : AP-HM

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Marseille : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Marseille : Hôpital Sainte Marguerite

Patients are needed to participate in a clinical research study evaluating masitinib and Dacarbazine for the treatment of Metastatic Melanoma

Marseille Cedex 05 : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Marseille Cedex 5 : Local Institution

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Marseille Cedex 5 : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Lung Cancer, Non-Small Cell

Marseille cedex 5 : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Marseille cedex 5 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Montauban : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Montivilliers : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Montpellier : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Lung Cancer, Non-Small Cell

Montpellier : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Montpellier : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Montpellier cedex 5 : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of NY-ESO-1-positive, Unresectable and Progressive Metastatic Cutaneous Melanoma

Montpellier cedex 5 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Nancy : Hôpital d'Enfants, CHU Nancy Updated

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Nantes : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Lung Cancer, Non-Small Cell

Nantes : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Nantes : Hôpital hôtel-Dieu

A clinical trial to evaluate treatments using DT01 for patients with Local Metastatic Melanoma

Nantes : Centre Hospitalier Universitaire de Nantes

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Nantes : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Nantes Cedex 1 : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of NY-ESO-1-positive, Unresectable and Progressive Metastatic Cutaneous Melanoma

Nice : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Nice : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Nice : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Nouvelle caledonie : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Orléans : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Paris : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Paris : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of NY-ESO-1-positive, Unresectable and Progressive Metastatic Cutaneous Melanoma

Paris : Groupe Hospitalier Cochin - Hôtel Dieu-Broca

A clinical trial to evaluate treatments using DT01 for patients with Local Metastatic Melanoma

Paris : Institut Curie

A clinical trial to evaluate treatments using DT01 for patients with Local Metastatic Melanoma

Paris : Hôpital Saint-Louis

A clinical trial to evaluate treatments using DT01 for patients with Local Metastatic Melanoma

Paris : AP-HP Hôpital Saint Louis

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Paris : Novartis Investigative Site

A Phase 1 clinical study for patients with Uveal Melanoma

Paris : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Paris : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Paris : Institut Curie

Patients are needed to participate in a clinical research study evaluating 2B3-101, Trastuzumab, 2B3-101 60 mg/m2 every 4 weeks and 2B3-101 50 mg/m2 every 3 weeks

Paris : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Paris : MSD France

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Paris : Institut Curie Updated

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Paris Cedex 10 : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Paris Cedex 10 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Paris cedex 18 : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Pierre Benite : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Pierre Benite : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Pierre Bénite : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Pierre-Benite Cedex : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Pierre-Bénite cedex : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Poitiers : CHU Milétrie

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Quimper : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Reims : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Reims Cedex : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Rennes : CHU Pontchaillou

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Rennes : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Rennes Cedex : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Rouen : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Saint-Etienne : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Strasbourg Cedex : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Toulouse : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Toulouse : CHU Hôpital Larrey

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Toulouse : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Toulouse Cedex : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Toulouse Cedex 3 : Novartis Investigative Site

A clinical research study of LGX818 for the treatment of Melanoma and Metastatic Colorectal Cancer

Toulouse Cedex 9 : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Toulouse cedex 9 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Tours : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Tours Cedex 9 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Vandoeuvre les Nancy : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Vandoeuvre Les Nancy : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Villejuif : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Villejuif : Institut Gustave Roussy

Patients are needed to participate in a clinical research study evaluating 2B3-101, Trastuzumab, 2B3-101 60 mg/m2 every 4 weeks and 2B3-101 50 mg/m2 every 3 weeks

Villejuif : Institut Gustave Roussy Updated

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Villejuif Cedex : Local Institution

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Villejuif Cedex : Novartis Investigative Site

A clinical research study of LGX818 for the treatment of Melanoma and Metastatic Colorectal Cancer

Villejuif cedex : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Germany

Aachen : Dept of Dermatology, University of Aachen

A Phase 3 clinical study for patients with Melanoma

Augsburg : Updated

A clinical research study for the treatment of Malignant Melanoma

Augsburg : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Augsburg : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Augsburg : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Berlin : Updated

A clinical research study for the treatment of Malignant Melanoma

Berlin : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Berlin : Dept of Dermatology, University of Berlin Charite

A Phase 3 clinical study for patients with Melanoma

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Berlin : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Berlin : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Bochum : Updated

A clinical research study for the treatment of Malignant Melanoma

Bochum : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Bochum : Dept of Dermatology, University of Bochum

A Phase 3 clinical study for patients with Melanoma

Bochum : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Bochum : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Bonn : Updated

A clinical research study for the treatment of Malignant Melanoma

Bonn : Updated

A clinical research study for the treatment of Malignant Melanoma

Bonn : Neurologische Universitaetsklinik Bonn

A clinical trial seeking patients for a research study for the treatment of Leptomeningeal Metastasis From Malignant Melanoma

Bonn : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Bonn : Medizinisches Zentrum Bonn Friedensplatz

A Phase 3 clinical study for patients with Melanoma

Bonn : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Buxtehude : Updated

A clinical research study for the treatment of Malignant Melanoma

Buxtehude : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Buxtehude : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma, Neoplasms

Buxtehude : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Buxtehude : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Buxtehude : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Chemnitz : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Darmstadt : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Dessau-Roblau : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Dortmund : Local Institution

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Dresden : Updated

A clinical research study for the treatment of Malignant Melanoma

Dresden : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Düsseldorf : Updated

A clinical research study for the treatment of Malignant Melanoma

Düsseldorf : Research site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Düsseldorf : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Erfurt : Updated

A clinical research study for the treatment of Malignant Melanoma

Erfurt : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Erfurt : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Erfurt : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Erlangen : Local Institution

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Erlangen : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Erlangen : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Essen : Updated

A clinical research study for the treatment of Malignant Melanoma

Essen : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Essen : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma, Neoplasms

Essen : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Essen : Dept of Dermatology, University of Essen

A Phase 3 clinical study for patients with Melanoma

Essen : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Essen : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Essen : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Essen : Medizinische Fakultät der Universität Duisburg-Essen

Patients are needed to participate in a clinical research study evaluating RBL001/RBL002 for the treatment of Melanoma

Essen : Novartis Investigative Site

Patients are needed to participate in a clinical research study of AEB071 and MEK162 to evaluate Uveal Melanoma

Frankfurt : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Frankfurt / Main : Dept of Dermatology, University of Frankfurt

A Phase 3 clinical study for patients with Melanoma

Frankfurt am Main : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Frankfurt am Main : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Frankfurt/Oder : Dermatology, Klinikum Frankfurt/Oder

A Phase 3 clinical study for patients with Melanoma

Freiburg : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of NY-ESO-1-positive, Unresectable and Progressive Metastatic Cutaneous Melanoma

Freiburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Freiburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Freiburg : University Medical Center Freiburg, Department of Dermatology

Patients are needed to participate in a clinical research study evaluating psycho-oncological intervention for the treatment of Malignant Melanoma

Freiburg : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Gera : Updated

A clinical research study for the treatment of Malignant Melanoma

Gera : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Gera : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Gera : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Göttingen : Updated

A clinical research study for the treatment of Malignant Melanoma

Greifswald : Updated

A clinical research study for the treatment of Malignant Melanoma

Hamburg : Local Institution

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Hamburg : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Hannover : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Lung Cancer, Non-Small Cell

Hannover : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Hannover : Dept of Dermatology, University of Hannover

A Phase 3 clinical study for patients with Melanoma

Hannover : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Hannover : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Hannover : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Hannover : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Heidelberg : Updated

A clinical research study for the treatment of Malignant Melanoma

Heidelberg : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Heidelberg : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of NY-ESO-1-positive, Unresectable and Progressive Metastatic Cutaneous Melanoma

Heidelberg : Updated

A clinical trial to evaluate treatments using vemurafenib and phenprocoumon for patients with Malignant Melanoma, Neoplasms

Heidelberg : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Heidelberg : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Heidelberg : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Heilbronn : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Homburg/Saar : Dept of Dermatology, Saarland University

A Phase 3 clinical study for patients with Melanoma

Jena : Updated

A clinical research study for the treatment of Malignant Melanoma

Jena : Dept of Dermatology, University of Jena

A Phase 3 clinical study for patients with Melanoma

Jena : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Kassel : Updated

A clinical research study for the treatment of Malignant Melanoma

Kiel : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Kiel : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Kiel : Dept of Dermatology, University of Schleswig-Holstein Campus Kiel

A Phase 3 clinical study for patients with Melanoma

Kiel : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Kiel : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Kiel : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Kiel : Updated

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Kiel : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Koblenz : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Koeln : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Koeln : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Koeln : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Köln : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Köln : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Köln : University Medical Center Collogne, Department of Dermatology

Patients are needed to participate in a clinical research study evaluating psycho-oncological intervention for the treatment of Malignant Melanoma

Leer : Updated

A clinical research study for the treatment of Malignant Melanoma

Leipzig : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Leipzig : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Lübeck : Updated

A clinical research study for the treatment of Malignant Melanoma

Lübeck : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Lübeck : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Lüdenscheid : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Ludwigshafen : Updated

A clinical research study for the treatment of Malignant Melanoma

Ludwigshafen : Dermatology, Klinikum Ludwishafen

A Phase 3 clinical study for patients with Melanoma

Ludwigshafen : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Luebeck : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of NY-ESO-1-positive, Unresectable and Progressive Metastatic Cutaneous Melanoma

Luebeck : Dept of Dermatology, University of Schleswig-Holstein Campus Luebeck

A Phase 3 clinical study for patients with Melanoma

Luebeck : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Luebeck : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Magdeburg : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Magdeburg : Dept of Dermatology, Univeristy of Magdeburg

A Phase 3 clinical study for patients with Melanoma

Magdeburg : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Magdeburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Mainz : Updated

A clinical research study for the treatment of Malignant Melanoma

Mainz : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Lung Cancer, Non-Small Cell

Mainz : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Mainz : Hautklinik und Poliklinik Universitätsmedizin der Johannes-Gutenberg Universität Mainz

A clinical trial to evaluate treatments using IVAC MUTANOME, RBL001/RBL002 for patients with Melanoma

Mainz : Updated

A clinical trial to evaluate treatments using vemurafenib and phenprocoumon for patients with Malignant Melanoma, Neoplasms

Mainz : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Mainz : Dept of Dermatology, University of Mainz

A Phase 3 clinical study for patients with Melanoma

Mainz : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Mainz : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Mainz : Universtitätsmedizin der Johannes-Gutenberg Universtität

Patients are needed to participate in a clinical research study evaluating RBL001/RBL002 for the treatment of Melanoma

Mainz : Updated

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Mainz : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Manheim : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Mannheim : Updated

A clinical research study for the treatment of Malignant Melanoma

Mannheim : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Mannheim : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma, Neoplasms

Mannheim : Dept of Dermatology, University of Mannheim

A Phase 3 clinical study for patients with Melanoma

Mannheim : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Mannheim : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Mannheim : Universitätsklinik Mannheim

Patients are needed to participate in a clinical research study evaluating RBL001/RBL002 for the treatment of Melanoma

Marburg : Dept of Dermatology, University of Marburg

A Phase 3 clinical study for patients with Melanoma

Marburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Muenchen : Dept of Dermatology, University of Muenchen

A Phase 3 clinical study for patients with Melanoma

Muenchen : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Muenchen : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Muenchen : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Muenchen : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Muenchen : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Muenchen : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Muenster : Updated

A clinical research study for the treatment of Malignant Melanoma

Muenster : Updated

A clinical research study for the treatment of Malignant Melanoma

Muenster : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Muenster : Dept of Dermatology, University of Muenster

A Phase 3 clinical study for patients with Melanoma

Muenster : Dept of Medical Oncology, Fachklinik Hornheide

A Phase 3 clinical study for patients with Melanoma

Muenster : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

München : Research site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

München : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Münster : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Münster : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Nuernberg : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Nuernberg : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Nuernberg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Nürnberg : Updated

A clinical research study for the treatment of Malignant Melanoma

Plauen : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Plauen : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Quedlinburg : Updated

A clinical research study for the treatment of Malignant Melanoma

Quedlinburg : Dermatology, Klinikum Dorothea Christiane Erxleben

A Phase 3 clinical study for patients with Melanoma

Quedlinburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Quedlinburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Quedlinburg : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Recklinghausen : Updated

A clinical research study for the treatment of Malignant Melanoma

Recklinghausen : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Regensburg : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Regensburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Regensburg : University of Regensburg

Patients are needed to participate in a clinical research study evaluating dacarbazine (DTIC), Trofosfamide, Etoricoxib, Pioglitazone, Temsirolimus for the treatment of Advanced Melanoma

Rostock : Updated

A clinical research study for the treatment of Malignant Melanoma

Schwerin : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Schwerin : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Stade : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Tübingen : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Tübingen : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Tübingen : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Tuebingen : Updated

A clinical research study for the treatment of Malignant Melanoma

Tuebingen : University Hospital

A clinical research study of Arm 1: L19IL2 + Dacarbazine and Arm 2: Dacarbazine for the treatment of Metastatic Melanoma Stage IV

Tuebingen : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Tuebingen : Dept of Dermatology, University of Tuebingen

A Phase 3 clinical study for patients with Melanoma

Tuebingen : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Tuebingen : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Tuebingen : Updated

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Ulm : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Ulm : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Ulm : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Wiesbaden : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Wuerzburg : Dept of Dermatology, University of Wuerzburg

A Phase 3 clinical study for patients with Melanoma

Wuerzburg : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Wuerzburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Wurzburg : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Würzburg : Updated

A clinical research study for the treatment of Malignant Melanoma

Würzburg : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Würzburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Würzburg : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Würzburg : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Greece

Athens : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Athens : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

N. Faliro : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Thessaloniki : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma, Neoplasms

Thessaloniki : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Thessaloniki : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Hungary

Budapest : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma, Neoplasms

Ireland

Cork : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Cork : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Dublin : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Dublin : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Dublin : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Galway : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Tullamore : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Israel

Beer Sheva : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Beer Sheva : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Haifa : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Haifa : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Haifa : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Jerusalem : Oncology institute, Shaare Zedek Medical Center

A clinical research study of IVIG and Biological Therapy for the treatment of Cancer of Colon, Malignant Melanoma or Urologic Cancer

Jerusalem : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Jerusalem : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Jerusalem : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Jerusalem : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Jerusalem : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Petach Tikva : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Ramat Gan : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Ramat Gan : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Ramat-Gan : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Tel Aviv : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Tel Aviv : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Tel Hashomer : Oncology Institute, Sheba Medical Center

A clinical research study of IVIG and Biological Therapy for the treatment of Cancer of Colon, Malignant Melanoma or Urologic Cancer

Tel Hashomer : Ella Institute, Oncology institute, Sheba Medical Center

A clinical research study of IVIG and Biological Therapy for the treatment of Cancer of Colon, Malignant Melanoma or Urologic Cancer

Tel Hashomer : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Tel Hashomer : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Tel-Aviv : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Italy

Ancona : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Ancona : A.O. UNIVERSITARIA OSPEDALI RIUNITI - OSPEDALE UMBERTO I DI ANCONA - ANCONA (AN) (Italy)

Patients are needed to participate in a clinical research study of F16IL2 in combination with paclitaxel to evaluate Tumour or Breast Cancer

Bari : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Bari : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Bergamo : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Bergamo : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Bergamo : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Brescia : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Brescia : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Candiolo : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Candiolo (TO) : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Genova : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Genova : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Genova : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Genova : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Genova : Children's Hospital Largo Updated

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Genova : Updated

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Meldola : Irst - Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori - Meldola (Fc)

Patients are needed to participate in a clinical research study of F16IL2 in combination with paclitaxel to evaluate Tumour or Breast Cancer

Meldola - FC : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Milan : Fondazione IRCCS Istituto Nazionale dei Tumori

A clinical research study of L19IL2+L19TNF for the treatment of Malignant Melanoma, Skin

Milan : European Institute of Oncology

Patients are needed to participate in a clinical research study of F16IL2 in combination with paclitaxel to evaluate Tumour or Breast Cancer

Milan : Istituto Nazionale Tumori Updated

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Milano : Updated

A clinical research study for the treatment of Malignant Melanoma

Milano : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Lung Cancer, Non-Small Cell

Milano : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Milano : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Milano : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of NY-ESO-1-positive, Unresectable and Progressive Metastatic Cutaneous Melanoma

Milano : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of NY-ESO-1-positive, Unresectable and Progressive Metastatic Cutaneous Melanoma

Milano : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Milano : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Milano : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Milano : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Milano : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Milano : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Milano : Updated

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Modena : A.O. UNIVERSITARIA POLICLINICO DI MODENA (Italy)

Patients are needed to participate in a clinical research study of F16IL2 in combination with paclitaxel to evaluate Tumour or Breast Cancer

Napoli : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Napoli : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Napoli : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Padova : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Padova : Vanna Chiarion-Sileni, MD

A clinical trial to evaluate treatments using Anti-B-RAF for patients with Metastatic Melanoma

Padova : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Padova : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Padova : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Padova : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Pavia : Updated

A clinical research study for the treatment of Malignant Melanoma

Pisa : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Roma : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Roma : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Roma : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Roma : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Roma : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Roma : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Roma : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Roma : Updated

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Rome : MSD Italia S.r.l.

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Rozzano : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Siena : Azienda Ospedaliera Universitaria Senese

A clinical research study of Arm 1: L19IL2 + Dacarbazine and Arm 2: Dacarbazine for the treatment of Metastatic Melanoma Stage IV

Siena : Azienda Ospedaliera Universitaria Senese

A clinical research study of L19IL2+L19TNF for the treatment of Malignant Melanoma, Skin

Siena : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Siena : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Siena : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Siena : Azienda Ospedaliera Universitaria Senese

Patients are needed to participate in a clinical research study of F16IL2 in combination with paclitaxel to evaluate Tumour or Breast Cancer

Torino : l'Azienda Ospedaliera Regina Margherita - Sant Anna Updated

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Japan

Chuo-ku : Local Institution

A Phase 2 clinical study for patients with Melanoma

Chuo-ku : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Chuo-Shi : Local Institution

A Phase 2 clinical study for patients with Melanoma

Fukuoka-Shi : Local Institution

A Phase 2 clinical study for patients with Melanoma

Kumamoto-shi : Local Institution

A clinical trial seeking patients for a research study for the treatment of Melanoma

Kumamoto-Shi : Local Institution

A Phase 2 clinical study for patients with Melanoma

Matsumoto : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Matsumoto-shi : Local Institution

A clinical trial seeking patients for a research study for the treatment of Melanoma

Matsumoto-shi : Local Institution

A Phase 2 clinical study for patients with Melanoma

Shizuoka : GSK Investigational Site

A clinical research study of dabrafenib and trametinib for the treatment of Solid Tumours

Shizuoka : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Sunto-gun : Local Institution

A clinical trial seeking patients for a research study for the treatment of Melanoma

Sunto-Gun : Local Institution

A Phase 2 clinical study for patients with Melanoma

Tokyo : GSK Investigational Site

A clinical research study of dabrafenib and trametinib for the treatment of Solid Tumours

Korea, Republic of

Seoul : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Seoul : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Seoul : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Seoul : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Seoul : MSD Korea LTD

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Seoul : Updated

Patients are needed to participate in a clinical research study of vemurafenib and tizanidine to evaluate Malignant Melanoma, Neoplasms

Seoul : Updated

Patients are needed to participate in a clinical research study of vemurafenib and tizanidine to evaluate Malignant Melanoma, Neoplasms

Seoul : Updated

Patients are needed to participate in a clinical research study of vemurafenib and tizanidine to evaluate Malignant Melanoma, Neoplasms

Mexico

Leon, Guanajato : Local Institution

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Netherlands

Amsterdam : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma, Neoplasms

Amsterdam : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of NY-ESO-1-positive, Unresectable and Progressive Metastatic Cutaneous Melanoma

Amsterdam : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Amsterdam : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Amsterdam : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Amsterdam : Vrije Universiteit medisch centrum (Vumc)

Patients are needed to participate in a clinical research study evaluating 2B3-101, Trastuzumab, 2B3-101 60 mg/m2 every 4 weeks and 2B3-101 50 mg/m2 every 3 weeks

Amsterdam : Antoni van Leeuwenhoek Ziekenhuis

Patients are needed to participate in a clinical research study evaluating 2B3-101, Trastuzumab, 2B3-101 60 mg/m2 every 4 weeks and 2B3-101 50 mg/m2 every 3 weeks

Amsterdam : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Amsterdam : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Breda : Updated

A clinical research study for the treatment of Malignant Melanoma

Groningen : Updated

A clinical research study for the treatment of Malignant Melanoma

Groningen : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Groningen : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Groningen : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Heerlen : Updated

A clinical research study for the treatment of Malignant Melanoma

Leeuwarden : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Leiden : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Leiden : Novartis Investigative Site

A Phase 1 clinical study for patients with Uveal Melanoma

Leiden : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Leiden : Leids Universitair Medisch Centrum (LUMC)

Patients are needed to participate in a clinical research study evaluating 2B3-101, Trastuzumab, 2B3-101 60 mg/m2 every 4 weeks and 2B3-101 50 mg/m2 every 3 weeks

Leiden : Novartis Investigative Site

Patients are needed to participate in a clinical research study of AEB071 and MEK162 to evaluate Uveal Melanoma

Maastricht : Updated

A clinical research study for the treatment of Malignant Melanoma

Maastricht : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma, Neoplasms

Maastricht : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of NY-ESO-1-positive, Unresectable and Progressive Metastatic Cutaneous Melanoma

Maastricht : Maastricht Universitair Medisch Centrum

Patients are needed to participate in a clinical research study evaluating 2B3-101, Trastuzumab, 2B3-101 60 mg/m2 every 4 weeks and 2B3-101 50 mg/m2 every 3 weeks

Maastricht : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Nijmegen : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LEE011 and MEK162 to evaluate Locally Advanced or Metastatic NRAS Mutant Melanoma

Rotterdam : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of NY-ESO-1-positive, Unresectable and Progressive Metastatic Cutaneous Melanoma

Rotterdam : Novartis Investigative Site

A Phase 1 clinical study for patients using LGK974

Rotterdam : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Rotterdam : Erasmus MC

Patients are needed to participate in a clinical research study evaluating 2B3-101, Trastuzumab, 2B3-101 60 mg/m2 every 4 weeks and 2B3-101 50 mg/m2 every 3 weeks

Rotterdam : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Utrecht : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma, Neoplasms

Utrecht : Updated

A clinical trial to evaluate treatments using vemurafenib and phenprocoumon for patients with Malignant Melanoma, Neoplasms

Utrecht : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Utrecht : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LEE011 and MEK162 to evaluate Locally Advanced or Metastatic NRAS Mutant Melanoma

Zwolle : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Zwolle : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

New Zealand

Auckland : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma, Neoplasms

Auckland : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Christchurch : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Christchurch : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Hamilton : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Palmerston North : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Tauranga : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Wellington : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Norway

Ålesund : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Oslo : Oslo University Hospital Radiumhospitalet

A clinical trial to evaluate treatments using LTX-315 for patients with Transdermally Accessible Tumours

Oslo : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Stavanger : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Poland

Bydgoszcz : Updated

A clinical research study for the treatment of Malignant Melanoma

Gdansk : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Konin : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Lodz : Updated

A clinical research study for the treatment of Malignant Melanoma

Olsztyn : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Opole : Updated

A clinical research study for the treatment of Malignant Melanoma

Poznan : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Poznan : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Poznan : WCO (Great Poland Cancer Centre)

Patients are needed to participate in a clinical research study of AGI-101H Vaccine to evaluate Melanoma

Warszawa : Updated

A clinical research study for the treatment of Malignant Melanoma

Warszawa : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Warszawa : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Wroclaw : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Portugal

Evora : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Lisboa : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Lisboa : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Lisboa : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma, Neoplasms

Porto : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Porto : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma, Neoplasms

Russian Federation

Chelyabinsk : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Kazan : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Krasnodar : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Moscow : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Moscow : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Moscow :

A Phase 1/Phase 2 clinical study for patients with Advanced Solid Tumors

Moscow : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Moscow : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Moscow : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Moscow : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Ryazan : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Ryazan : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Saint-Petersburg : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

St. Petersburg : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

St. Petersburg : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

St. Petersburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

St. Petersburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Stavropol : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Volzhsky : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Serbia

Belgrade : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Belgrade : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Belgrade : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Sremska Kamenica : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Slovakia

Bratislava : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

South Africa

Bloemfontein : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Bloemfontein : Updated

Patients are needed to participate in a clinical research study evaluating Zelboraf for the treatment of Malignant Melanoma

Cape Town : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Cape Town : Updated

Patients are needed to participate in a clinical research study evaluating Zelboraf for the treatment of Malignant Melanoma

Cape Town : Updated

Patients are needed to participate in a clinical research study evaluating Zelboraf for the treatment of Malignant Melanoma

Cape Town : Updated

Patients are needed to participate in a clinical research study of vemurafenib and rifampin to evaluate Malignant Melanoma, Neoplasms

Durban : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Groenkloof : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Johannesburg : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Johannesburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Johannesburg : Updated

Patients are needed to participate in a clinical research study evaluating Zelboraf for the treatment of Malignant Melanoma

Observatory : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Pietermaritzburg : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Port Elizabeth : Updated

Patients are needed to participate in a clinical research study of vemurafenib and rifampin to evaluate Malignant Melanoma, Neoplasms

Pretoria : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Pretoria : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Pretoria : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Pretoria : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Pretoria : Updated

Patients are needed to participate in a clinical research study evaluating Zelboraf for the treatment of Malignant Melanoma

Sandton : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Sandton : Updated

Patients are needed to participate in a clinical research study evaluating Zelboraf for the treatment of Malignant Melanoma

Spain

Badalona : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Badalona : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Barcelona : Novartis Investigative Site

A clinical research study of LGX818 for the treatment of Melanoma and Metastatic Colorectal Cancer

Barcelona : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Barcelona : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma, Neoplasms

Barcelona : Novartis Investigative Site

A Phase 1 clinical study for patients using LGK974

Barcelona : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Barcelona : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Barcelona : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Barcelona : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Barcelona : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Barcelona : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Barcelona : Hospital Universitario Vall D`Hebron Updated

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Cartagena (Murcia) : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Esplugues de Llobregat : Local Institution

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Las Palmas De Gran Canaria : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Las Palmas de Gran Canarias : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

L'Hospitalet de Llobregat : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

L'Hospitalet de Llobregat : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma, Neoplasms

L'Hospitalet de Llobregat : Updated

A clinical trial to evaluate treatments using vemurafenib and phenprocoumon for patients with Malignant Melanoma, Neoplasms

l'Hospitalet de Llobregat : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Madrid : Novartis Investigative Site

A clinical research study of LGX818 for the treatment of Melanoma and Metastatic Colorectal Cancer

Madrid : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Madrid : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma, Neoplasms

Madrid : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma, Neoplasms

Madrid : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma, Neoplasms

Madrid : Updated

A clinical trial to evaluate treatments using vemurafenib and phenprocoumon for patients with Malignant Melanoma, Neoplasms

Madrid : Updated

A clinical trial to evaluate treatments using vemurafenib and phenprocoumon for patients with Malignant Melanoma, Neoplasms

Madrid : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Madrid : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Madrid : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Madrid : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Madrid : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Madrid : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Madrid : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Madrid : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Madrid : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Madrid : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Madrid : Merck Sharp and Dohme de Espana S.A.

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Madrid : Novartis Investigative Site

Patients are needed to participate in a clinical research study of AEB071 and MEK162 to evaluate Uveal Melanoma

Madrid : Spanish National Cancer Research Centre Updated

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Majadahonda : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Málaga : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Málaga : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Marbella : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Palma de Mallorca : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Pamplona : Local Institution

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma or Metastatic Melanoma

Pamplona : Updated

A clinical trial to evaluate treatments using vemurafenib and phenprocoumon for patients with Malignant Melanoma, Neoplasms

Pamplona : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Pamplona : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Pamplona : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Pamplona : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Pamplona : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

San Sebastián : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Santander : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Santiago de Compostela : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Sevilla : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Sevilla : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Toledo : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Valencia : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Valencia : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Valencia : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Valencia : Unidad de Oncologia Pediatrica, Hospital Universitario la Fe Updated

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Sweden

Göteborg : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Göteborg : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Göteborg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Jönköping : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Karlskrona : Updated

A clinical research study for the treatment of Malignant Melanoma

Lund : Lunds Universitetssjukhus

A Phase 2 clinical study for patients with Malignant Melanoma

Lund : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Lund : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Stockholm : Södersjukhuset

A Phase 2 clinical study for patients with Malignant Melanoma

Stockholm : Karolinska Sjukhuset

A Phase 2 clinical study for patients with Malignant Melanoma

Stockholm : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Stockholm : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Stockholm : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Umeå : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Umeå : Norrlands Universitetssjukhus

A Phase 2 clinical study for patients with Malignant Melanoma

Uppsala : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Uppsala : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Växjö : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Switzerland

Baden : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Basel : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Basel : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Basel : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Chur : Novartis Investigative Site

A clinical research study of LGX818 for the treatment of Melanoma and Metastatic Colorectal Cancer

Chur : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Lausanne : Novartis Investigative Site

A Phase 1 clinical study for patients with Metastatic Melanoma and Merkel Cell Carcinoma

Lausanne : Oncology Department, CHUV

Patients are needed to participate in a clinical research study evaluating 2 vaccine injections in 1 limb, 2 vaccine injections in different limbs and 2 vaccine injections in different limbs, the vaccine does not contain the MHC class II peptide MAGE-A3-DP4 for the treatment of Melanoma

Lugano : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Zuerich : Novartis Investigative Site

A Phase 1 clinical study for patients with Metastatic Melanoma and Merkel Cell Carcinoma

Zürich : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of NY-ESO-1-positive, Unresectable and Progressive Metastatic Cutaneous Melanoma

Zürich : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Zürich : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Zürich : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Zürich : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Taiwan

Taichung : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Taipei : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Taoyuan : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Turkey

Adana : Updated

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Adana : Updated

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Afyon : Updated

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Ankara : Updated

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Ankara : Updated

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Ankara : Updated

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Ankara : Updated

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Ankara : Updated

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Ba?kesir : Updated

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Bursa : Updated

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Diyarbakir : Updated

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Edirne : Updated

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Erzurum : Updated

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Gaziantep : Updated

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Isparta : Updated

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Istanbul : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Istanbul : Updated

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Istanbul : Updated

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Istanbul : Updated

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Istanbul : Updated

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Istanbul : Updated

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Izmir : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Izmir : Updated

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Izmir : Updated

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Kayseri : Updated

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Konya : Updated

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Malatya : Updated

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

S?hhiye, ANKARA : Updated

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Tokat : Updated

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Trabzon : Updated

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Ukraine

Dnipropetrovsk : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Donetsk : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Khmelnytskyi : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Kyiv : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Kyiv : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Lviv : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Lviv : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Sumy : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

United Kingdom

Bebington : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Birmingham : Queen Elizabeth Hospital

A Phase 1 clinical study for patients with Malignant Melanoma

Birmingham : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Brighton : Updated

A clinical research study for the treatment of Malignant Melanoma

Bristol : Updated

A clinical research study for the treatment of Malignant Melanoma

Bristol : Local Institution

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Bristol : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Cambridge : Updated

A clinical research study for the treatment of Malignant Melanoma

Cambridge : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Cambridge : Cambridge University Hospitals NHS Foundation Trust

A clinical trial to evaluate treatments using Pazopanib for patients

Cambridge : Addenbrooke's Hospital

A Phase 1 clinical study for patients with Malignant Melanoma

Cambridge : Cambridge University Hospitals NHS Foundation Trust (Addenbrooke's Hospital)

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Cambridge : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Cambridge : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Cardiff : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Chelmsford : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of NY-ESO-1-positive, Unresectable and Progressive Metastatic Cutaneous Melanoma

Chelmsford : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Cheltenham : Updated

A clinical research study for the treatment of Malignant Melanoma

Dorchester : Updated

A clinical research study for the treatment of Malignant Melanoma

Edgbaston, Birmingham : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Edinburgh : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Exeter : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Glasgow : The Beatson Institute

A Phase 1 clinical study for patients with Malignant Melanoma

Glasgow : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Guildford : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Hoddesdon : Merck Sharp & Dohme Ltd.

Patients are needed to participate in a clinical research study for the treatment of Cancer, Solid Tumor

Hull : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Kings Lynn : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Leeds : Updated

A clinical research study for the treatment of Malignant Melanoma

Leeds : St James University Hospital

A clinical research study of CVA21 for the treatment of Non-small Cell Lung Cancer, Castrate-resistant Prostate Cancer, Melanoma or Bladder Cancer

Leeds : St James' Institute of Oncology

A clinical trial to evaluate treatments using SCIB1 for patients with Malignant Melanoma

Leeds : St James Hospital

A Phase 1 clinical study for patients with Malignant Melanoma

Leeds : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Leeds : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Leeds : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Leeds : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Leicester : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of NY-ESO-1-positive, Unresectable and Progressive Metastatic Cutaneous Melanoma

Lincoln : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

London : Updated

A clinical research study for the treatment of Malignant Melanoma

London : Updated

A clinical research study for the treatment of Malignant Melanoma

London : Updated

A clinical research study for the treatment of Malignant Melanoma

London : Institute of Cancer Research

A clinical research study of CVA21 for the treatment of Non-small Cell Lung Cancer, Castrate-resistant Prostate Cancer, Melanoma or Bladder Cancer

London : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

London : Guy's Hospital

A clinical trial to evaluate treatments using LTX-315 for patients with Transdermally Accessible Tumours

London : The Royal Marsden Hospital

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

London : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

London : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

London : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

London : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

London : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

London : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

London : King's College London Guy's Hospital Campus

Patients are needed to participate in a clinical research study evaluating E7449 alone, E7449 plus TMZ and E7449 plus carboplatin and paclitaxel

London : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

London : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

London : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Manchester : Christie Hospital

A clinical trial to evaluate treatments using SCIB1 for patients with Malignant Melanoma

Manchester : The Christie NHS Foundation Trust

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Manchester : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Manchester : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Merseyside : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Newcastle : Local Institution

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Newcastle upon Tyne : Newcastle upon Tyne Hospitals

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Newcastle upon Tyne : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Newcastle upon Tyne : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Newcastle upon Tyne : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Newcastle upon Tyne : Updated

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Newcastle Upon Tyne and Wear : Newcastle Upon Tyne NHS Foundation Trust

Patients are needed to participate in a clinical research study evaluating E7449 alone, E7449 plus TMZ and E7449 plus carboplatin and paclitaxel

Northwood : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Northwood : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Norwich : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Nottingham : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Nottingham : Department of Clinical Oncology, City Hospital

A clinical trial to evaluate treatments using SCIB1 for patients with Malignant Melanoma

Nottingham : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Oxford : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Oxford : NIHR Biomedical Research Centre

A Phase 1 clinical study for patients with Malignant Melanoma

Oxford : Oxford University Hospitals NHS Trust

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Oxford : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Oxfordshire : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Plymouth : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Preston : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Preston : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Preston : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Preston : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Southampton : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of NY-ESO-1-positive, Unresectable and Progressive Metastatic Cutaneous Melanoma

Southampton : Department of Medical Oncology, Southampton General Hospital

A clinical trial to evaluate treatments using SCIB1 for patients with Malignant Melanoma

Southampton : Research Site

A Phase 2 clinical study for patients with N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

Southampton : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

St Helens : Updated

A clinical research study for the treatment of Malignant Melanoma

Surrey : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Sutton : Local Institution

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Sutton : GSK Investigational Site

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

Sutton : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Sutton : Royal Marsden Hospital Updated

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Sutton : Updated

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Taunton, Somerset : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Truro : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Truro, Cornwall : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Wirral : Updated

A clinical research study for the treatment of Malignant Melanoma

Wirral : Clatterbridge Centre for Oncology NHS Foundation Trust

A clinical trial to evaluate treatments using Dacarbazine and Sunitinib for patients with Metastatic Uveal Melanoma

Wirral : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Wolverhampton : Updated

A clinical research study for the treatment of Malignant Melanoma

Wolverhampton : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Wolverhampton : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Yeovil, Somerset : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma